Background: Triglycerides (TG)/high-density lipoprotein (HDL) cholesterol ratio is a marker of small/dense low-density lipoprotein particles, which are closely associated with various metabolic and vascular diseases. However, the role of TG/HDL cholesterol ratio in cerebrovascular diseases has not been well studied. In this study, we evaluated the relationship between TG/HDL cholesterol ratio and the presence of silent brain infarct (SBI) in a neurologically healthy population. Methods: We retrospectively evaluated consecutive participants in health check-ups between January 2006 and December 2013. SBI was defined as an asymptomatic, well-defined lesion with a diameter of ≥ 3 mm on T1- or T2-weighted images. TG/HDL cholesterol ratio was calculated after dividing absolute TG levels by absolute HDL cholesterol levels. Results: Of 3,172 healthy participants, 263 (8.3%) had SBI lesions. In multivariate analysis, TG/HDL cholesterol ratio was independently associated with SBI (adjusted odds ratio [aOR] = 1.17, 95% confidence interval [CI] = 1.04 to 1.32, P = 0.012). This association was prominent in males (aOR = 1.20, 95% CI = 1.04 to 1.40, P = 0.015), but not in females. Other lipid parameters, such as HDL cholesterol (aOR = 0.87, 95% CI = 0.75 to 1.00, P = 0.042), TG (aOR = 1.15, 95% CI = 1.02 to 1.31, P = 0.02), and total cholesterol/TG ratio (aOR = 0.86, 95% CI = 0.75 to 1.00, P = 0.043) also showed significant relationships with SBI, when they were respectively adjusted for confounders. In the analyses of the relationships between lipid parameters and SBI lesion burden, TG/HDL cholesterol ratio was positively correlated, and total cholesterol/TG ratio was negatively correlated with SBI lesion burden, in dose-response manners (P for trend = 0.015 and 0.002, respectively). Conclusions: The TG/HDL cholesterol ratio was positively associated with the prevalence of SBI in a neurologically healthy population.